AdVita Launches Axis Clinical Research Initiative for Shoulder Arthroplasty
2 reports, 1 independent
Updated Sep 21
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
AdVita announced the launch of Axis, a clinical research initiative focused on shoulder arthroplasty, on September 21, 2026. The program connects with shoulder surgeons to share clinical evidence based on more than 20 years of research. This data encompasses over 25,000 patients from 45 clinical sites worldwide, and has resulted in more than 250 peer-reviewed publications.
From prnewswire.com
Why it matters
The initiative builds on AdVita's extensive clinical data and aims to amplify generalizable conclusions from published studies. This effort provides a forum for researchers to explain how they integrate findings into clinical practice, ultimately aiming to improve patient outcomes.
From prnewswire.com
Who's involved
- AdVitaGlobal medical technology company launching the initiative.
- AXISThe clinical research initiative focused on shoulder arthroplasty.
- Joseph ZuckermanEmployed as a research team member at AdVita.